Choosing Off Page SEO Services: A Step-by-Step Guide

What actually separates a defensible off-page partner from a risky one

The vendor question worth asking is not how many backlinks arrive per month. It is what publisher those links come from, what claims sit on the linked page, what disclosure the placement carries, and what data the campaign touches on its way to an admissions call. Off-page SEO for a behavioral health operator is a compliance and editorial-quality problem wearing a link acquisition costume.

A defensible partner qualifies publishers on authorship, evidence, and transparency before pitching them, substantiates every health claim in outreach copy against FTC guidance ^{14, 15}, and treats material connections on guest posts, sponsored resources, and testimonial placements as disclosure obligations under the revised Endorsement Guides ¹⁶. A risky partner sends a spreadsheet of Domain Authority scores and a monthly link quota.

The gap between the two shows up in three places auditors and search engines both examine: the editorial quality of the referring page, the honesty of the disclosure attached to it, and the handling of any patient-adjacent data flowing through campaign landing pages, forms, or call tracking ^{12, 13}. What follows is a selection sequence built on those three axes:

1. Scope the engagement
2. Qualify the publisher
3. Substantiate the claim
4. Require the disclosure
5. Contain the data
6. Measure what the contract actually produced

Scope the engagement before you shortlist a vendor

Vendor shortlists collapse when the scope is written after the pitch decks arrive. A defensible off-page engagement starts with a written scope document that names the assets the vendor will produce, the publishers they are allowed to approach, the claims they are permitted to make, and the data they will be allowed to touch. That document is what turns a marketing purchase into an auditable one.

Five scope decisions belong in the brief before any outreach begins.

1. Asset inventory: guest post bylines, sponsored resource pages, linkable data studies, expert commentary placements, unlinked brand mentions, and any testimonial or review outreach. Each carries a different disclosure profile under the revised FTC Endorsement Guides ¹⁶ and, in the case of sponsored placements, the native-advertising transparency standard ³.
2. Geographic and topical target list, which should be drawn from search-demand research on help-seeking behavior in the states and metros the operator actually serves ¹¹, not from a generic outreach database.
3. Claim boundary. Any outcome, effectiveness, safety, or superiority language that could appear in a pitch, byline, anchor text, or headline needs an evidence trail before it ships ^{14, 15}.
4. Data boundary. If the campaign will ship landing pages, forms, call tracking, or retargeting pixels, the scope must specify which of those the vendor operates and under what agreements ¹².
5. Exclusions: publisher categories, tactics, and claim types the vendor is contractually prohibited from using.

Qualify the publisher, not the domain score

Substantiate every health claim before it leaves the vendor’s queue

Every treatment-related claim that appears in a pitch email, guest post byline, sponsored resource page, anchor text, or headline is an advertising claim under the FTC’s framework. The agency requires competent and reliable scientific evidence for objective health claims, whether those claims are stated directly or implied by context, layout, or surrounding testimonials ^{14, 15}. That standard applies to the vendor’s outreach copy the same way it applies to the operator’s own site.

The operational consequence is a substantiation workflow that runs before publication, not after a takedown request. Each proposed linkable asset should carry a claim inventory: the specific outcome, effectiveness, safety, or superiority statements it makes, the evidence backing each one, and the qualifying language required when evidence is limited or preliminary. Anchor text and headlines get the same review, because a hedged body paragraph does not cure an absolute headline ¹⁵. Vendors that cannot produce this inventory on request are shipping claims the operator will have to defend.

Content-completeness failures are the other half of the risk. A 2025 systematic review of online lymphedema patient resources found that 62.9% did not mention surgical treatment as an option, 75.2% failed to describe treatment risks, and 98.1% did not report quantitative risks ⁸. Those figures describe a specific condition, not addiction treatment, but they illustrate a recurring pattern in visible online health content: pages rank and attract links while omitting the treatment options and risk information a reader needs to make a decision. A substantiation workflow that requires balanced treatment descriptions, cited sources, and stated limitations catches those omissions before an outreach vendor pitches the page to a publisher — and gives the placement editorial value beyond the backlink itself.

Require disclosure discipline on guest posts, sponsored resources, and testimonials

Disclosure is where off-page campaigns most often fail two audits at once: the FTC’s and the publisher’s own editorial standards. The revised Endorsement Guides tightened the definition of “clear and conspicuous” and extended liability to advertisers, endorsers, and intermediaries, including agencies that place content on a treatment center’s behalf ¹⁶. A vendor contract that does not name who owns the disclosure obligation on each asset is a contract that owns it by default for the operator.

Three placement types carry distinct disclosure requirements:

• Paid guest posts and sponsored resource pages must be formatted so a reader cannot mistake them for independent editorial content; a “sponsored” label, an advertiser identifier, and placement of the disclosure adjacent to the content itself are the baseline the FTC’s native advertising guidance describes ³.
• Material connections — free products, discounted services, or ongoing commercial relationships between the operator and a contributing writer — must be disclosed with the endorsement, not buried in a bio or a site-wide footer ¹.
• Testimonial and recovery-story campaigns amplified on social carry the strictest placement rule: disclosures must be easy to notice, understand, and read in the same view as the endorsement, not hidden behind a “more” link or on a separate profile page ².

Two provisions belong in the outreach vendor’s statement of work. First, a prohibited-practices list that names fabricated reviews, employee reviews without disclosure, incentivized reviews without disclosure, and selectively suppressed negative reviews — each of which the 2023 revisions specifically address ¹⁶. Second, a disclosure specification for every asset class the vendor produces, written before pitching begins, that names the exact label wording, its placement, and who signs off on it. A disclosure does not cure a deceptive underlying claim ², so this discipline runs in parallel with the substantiation workflow, not as a substitute for it. Operators should keep a dated copy of every published placement and its disclosure as part of the outreach log; if the FTC or a publisher asks later, the artifact is the defense.

Treat data handling as vendor due diligence, not a separate IT topic

Outreach campaigns almost never ship links alone. They ship landing pages, forms, call tracking numbers, retargeting pixels, and CRM handoffs that feed admissions reporting. Each of those artifacts touches data that a covered entity is responsible for under HIPAA and, for substance-use records, under 42 CFR Part 2. A vendor selection process that reviews link quality but not data handling is auditing half the campaign.

HHS’s Office for Civil Rights has been explicit that pixels, cookies, analytics scripts, and other tracking technologies used on a covered entity’s pages, including unauthenticated pages that contain health-related information, must be configured so that any transmission of protected health information complies with the Privacy and Security Rules ¹². A retargeting pixel on a campaign landing page that captures IP address alongside a page URL indicating treatment interest can create a disclosure the operator did not intend. The vendor question is not whether pixels are allowed. It is which pixels the vendor plans to install, what data those pixels transmit, and whether the receiving platform will sign a Business Associate Agreement.

Part 2 raises the bar further for any data path that touches admissions. SAMHSA’s guidance is that patient-identifying information includes information by which a patient can be identified directly or through publicly available information, and that Part 2 generally requires patient consent for disclosures with limited exceptions ¹³. Call tracking recordings, CRM records tied to a campaign source, and referral reports shared with the vendor can all fall inside that definition depending on how they are configured. HIPAA marketing rules add a parallel constraint: using PHI, patient audience lists, or identifiable testimonials to build outreach targets or lookalike audiences generally requires authorization ^{4, 5}.

Four questions belong on every off-page vendor’s due-diligence sheet:

1. Which tracking technologies will the vendor deploy on campaign landing pages, and what fields will each transmit?
2. Will the vendor and every downstream platform sign a BAA where PHI may be involved?
3. How will call recordings, form submissions, and CRM handoffs be minimized, aggregated, or de-identified before the vendor sees them?
4. What is the incident response and data-deletion process when a campaign ends or a placement is retired?

Use search-demand research to shape target lists, not admissions forecasts

Search-demand data belongs in the scoping phase, where it shapes which states, metros, and treatment topics a vendor pitches. A peer-reviewed analysis of Google Trends queries for substance-use treatment across U.S. states found clear spatial and temporal signal, particularly for opioid-use disorders, and supports using search activity as an infoveillance tool for identifying where help-seeking behavior is concentrating ¹¹. That signal is useful for picking regional publisher lists, local resource-page themes, and digital PR angles tied to conditions the operator actually treats.

The same study is a warning against overreading the data. Search activity measures information-seeking, not completed admissions, clinical appropriateness, or payer mix ¹¹. A vendor that converts trend curves into projected admissions or revenue is selling a forecast the source does not support. The correct contract language treats search-demand research as an input to target selection and editorial calendars, with the vendor required to document why each geography and topic was chosen — and prohibited from restating those inputs as outcome guarantees in reporting or renewal conversations.

Scope shifts by operator footprint

For operators running more than one facility, off-page scope changes in three predictable ways: the number of local citation sets that must be maintained, the number of distinct geographic pitch lists a vendor has to build, and the volume of editorial and disclosure review the internal team has to absorb per asset. Single-site marketing managers can skim this section; regional and portfolio operators should use it to size the engagement before requesting proposals.

The variables below are counts and workload drivers, not dollar figures. Search-demand research supports segmenting the geographic pitch list by state and metro, because help-seeking behavior for substance-use treatment varies spatially and temporally rather than flowing evenly across a national footprint ¹¹. Disclosure and data-handling load scales with the number of vendors and platforms touching campaign assets, because material-connection disclosures attach to each placement and each intermediary ¹⁶, and any tracking platform that could receive PHI needs its own Business Associate Agreement ¹².

Two patterns are worth naming. Regional operators frequently underestimate the editorial review queue, because each linkable asset pitched into a second or third market often needs re-scoping for local providers, payer mix, and program availability. Portfolio operators frequently underestimate the disclosure and BAA register, because every new outreach vendor, call-tracking platform, and CRM integration multiplies the number of material connections and data flows that need documented ownership ^{16, 12}. Sizing these variables before the RFP prevents the common failure mode: a national scope priced against a single-site workflow.

Measurement, reporting, and what to require in the contract

The reporting a defensible off-page contract requires looks different from the dashboard most vendors ship. Backlink counts, referring domain totals, and month-over-month DA gains describe vendor activity; they do not describe whether the operator’s qualified organic visibility improved or whether the placements survive an FTC or OCR read. The contract should mandate reporting artifacts that answer both questions.

Six deliverables belong in the statement of work:

1. Publisher qualification sheet — a dated sheet for every prospect pitched, scored against the five-category rubric ¹⁰.
2. Claim inventory and substantiation file for every linkable asset shipped, with the evidence trail attached ^{14, 15}.
3. Disclosure log capturing the exact label wording and placement used on each published placement, retained as the artifact of record for the revised Endorsement Guides ¹⁶.
4. Data-flow map naming every tracking technology deployed on campaign landing pages, the fields transmitted, and the BAA status of each receiving platform ¹².
5. Outcome report tied to qualified organic sessions and admissions-adjacent conversions rather than link volume, with attribution built on minimized or aggregated data where Part 2 or HIPAA marketing constraints apply ^{4, 5, 13}.
6. Incident and takedown log covering any placement retired, disclosure corrected, or data path revised during the reporting period.

Two contract clauses do the work most disputes turn on. A termination-for-cause clause tied to missing substantiation, missing disclosure, or unauthorized tracking gives the operator an exit that does not depend on link performance. A data-deletion and asset-transfer clause specifies what happens to publisher relationships, placement inventories, disclosure records, and campaign data when the engagement ends. Vendors that resist either clause are describing how a future dispute will be resolved.